Leadership Overview
OneSource has 4 executives leading key functions including strategy, operations, finance, and global marketing.
Focused on delivering advanced pharmaceutical manufacturing solutions, OneSource drives innovation across biologics, complex injectables, and soft gelatin technologies to support global healthcare partners with high-quality, scalable production capabilities.
Focused on delivering advanced pharmaceutical manufacturing solutions, OneSource drives innovation across biologics, complex injectables, and soft gelatin technologies to support global healthcare partners with high-quality, scalable production capabilities.
Leadership Roles at OneSource
Neeraj Sharma - Chief Executive Officer
Neeraj Sharma, the Chief Executive Officer at OneSource, directs the overarching strategic vision and long-term growth trajectory for the organization. Sharma architects the integration of biologics, complex injectables, and soft gelatin platforms to ensure seamless end-to-end service delivery for global pharmaceutical clients. By overseeing the expansion of manufacturing capacity across the Bengaluru facilities, the Chief Executive Officer secures the company's competitive position within the evolving global supply chain. Neeraj Sharma maintains rigorous alignment with regulatory standards, ensuring that all five state-of-the-art sites meet US FDA and European Union requirements. This leadership role involves driving the commercialization of drug-device combinations and managing the transition toward high-growth therapeutic modalities. Through the optimization of operational efficiencies and the pursuit of aggressive revenue targets, the Chief Executive Officer fosters sustainable value creation for stakeholders while navigating the complexities of the international pharmaceutical landscape.
Anurag Bhagania - Chief Financial Officer
Anurag Bhagania, the Chief Financial Officer at OneSource, directs the financial planning, capital allocation, and fiscal reporting strategies necessary to support the company's growth objectives. Bhagania oversees the financial modeling for the projected 32 percent revenue increase in 2025 and the long-term goal of reaching 400 million dollars in sales by 2028. By managing the investment in state-of-the-art manufacturing infrastructure, the Chief Financial Officer ensures that the organization maintains the liquidity and capital structure required for sustained innovation. Anurag Bhagania collaborates with the executive team to evaluate market opportunities and assess the financial impact of supply chain diversification initiatives. This leadership role involves rigorous oversight of cost management and profitability metrics across all technology platforms. Through the implementation of robust financial controls and strategic investment planning, the Chief Financial Officer secures the fiscal health of the organization while enabling the expansion of global commercial operations.
Biju Mathew - Chief Operating Officer
Biju Mathew, the Chief Operating Officer at OneSource, manages the daily execution of manufacturing excellence across all five Bengaluru facilities. Mathew oversees the complex production workflows for biologics drug substance and drug product, ensuring that the annual output of 100 million injectable doses meets stringent quality benchmarks. By coordinating the technical teams and facility management, the Chief Operating Officer drives operational efficiency and supply chain reliability for over 50 global clients. Biju Mathew implements advanced manufacturing protocols to support the production of prefilled syringes and autoinjectors, directly impacting the company's ability to meet rising demand for GLP-1 drug-device combinations. This role requires constant monitoring of production metrics and resource allocation to maintain the high standards expected by international regulatory bodies. Through the systematic improvement of internal processes, the Chief Operating Officer ensures that the organization remains a preferred partner for complex sterile injectables and biologics manufacturing.
Shivaprasad Naikoti - Global Chief Marketing Officer, Head Oral Technologies Soft Gel Cdmo
Shivaprasad Naikoti, the Global Chief Marketing Officer, Head Oral Technologies Soft Gel Cdmo at OneSource, architects the commercial strategy and market positioning for the company's soft gelatin capsule and oral technology portfolios. Naikoti oversees the engagement with global pharmaceutical and biotechnology clients, driving the adoption of the organization's 2.4 billion annual capacity for soft gelatin production. By identifying emerging market trends and client needs, the Global Chief Marketing Officer, Head Oral Technologies Soft Gel Cdmo ensures that the company's service offerings remain aligned with the requirements of the international pharmaceutical sector. Shivaprasad Naikoti manages the promotion of the firm's end-to-end capabilities, focusing on the unique value proposition of the Bengaluru-based manufacturing sites. This role involves building strong partnerships with key industry stakeholders and expanding the company's footprint in major markets. Through targeted commercial initiatives, the Global Chief Marketing Officer, Head Oral Technologies Soft Gel Cdmo drives revenue growth and strengthens the brand's reputation for quality and technical expertise.
Explore Leadership Teams in Manufacturing
Founded in 1954 and headquartered in Suresnes, France, Servier international is an independent pharmaceutical company governed by a non-profit foundation. Their three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in their production centres around the world.
Company Leadership AA
VT
KP
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
JW
LP
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership
CH
KW
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership US
SJ
HK
Frequently Asked Questions Regarding OneSource Top Executives and Leadership Team
